NASDAQ:CYBX - Cyberonics Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileFinancialsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cyberonics, Inc. is a medical device company. The Company is engaged in the design, development, sale and marketing of medical devices for epilepsy, depression and heart failure. Its seminal product, the VNS Therapy System, is an implantable device that provides neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment-resistant depression (TRD). The Company's VITARIA System is an implantable device that provides a form of neuromodulation therapy for the treatment of chronic heart failure (CHF). The VNS Therapy System and its VITARIA System include an implantable pulse generator to stimulate the vagus nerve; a lead that conducts current pulses from the pulse generator to the vagus nerve; a surgical instrument to assist with the implant procedure; equipment to enable the treating physician to set the pulse generator stimulation parameters for the patient; instruction manuals, and in the VNS Therapy System, magnets to suspend or induce stimulation manually. Receive CYBX News and Ratings via Email Sign-up to receive the latest news and ratings for CYBX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Equipment SectorN/A SymbolNASDAQ:CYBX CUSIP23251P10 Webwww.livanova.cyberonics.com Phone+1-281-2287200 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins15.33% Return on Equity17.49% Return on Assets15.23% Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 Cyberonics (NASDAQ:CYBX) Frequently Asked Questions What is Cyberonics' stock symbol? Cyberonics trades on the NASDAQ under the ticker symbol "CYBX." What is the consensus analysts' recommendation for Cyberonics? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cyberonics in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Has Cyberonics been receiving favorable news coverage? News coverage about CYBX stock has trended somewhat positive on Saturday, Accern Sentiment reports. The research firm identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cyberonics earned a media sentiment score of 0.08 on Accern's scale. They also gave media headlines about the medical device company an impact score of 45.93 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future. How do I buy shares of Cyberonics? Shares of CYBX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. How can I contact Cyberonics? Cyberonics' mailing address is 100 Cyberonics Blvd, HOUSTON, TX 77058-2069, United States. The medical device company can be reached via phone at +1-281-2287200. MarketBeat Community Rating for Cyberonics (NASDAQ CYBX)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 188 (Vote Outperform)Underperform Votes: 147 (Vote Underperform)Total Votes: 335MarketBeat's community ratings are surveys of what our community members think about Cyberonics and other stocks. Vote "Outperform" if you believe CYBX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYBX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/21/2018 by MarketBeat.com StaffFeatured Article: How do investors use RSI to grade stocks?